Saga Kotaro

Affiliation and department：

Research field (1)： Tumor biology

Research theme for competitive and other funds (3)：

2022 - 2025 内因性危険シグナルHMGB1誘導性組織再生における骨髄間葉系幹細胞活性化機構解明
2016 - 2018 Escaping system from anti-tumor immunity of sphere-foriming cancer cell
2014 - 2016 Elucidation of anti-tumor acquired immune activation mechanism by Sendai viral particles

Papers (25)：

Airi Ishibashi, Yue Li, Yuuta Hisatomi, Noriko Ohta, Yuko Uegaki, Atsushi Tanemura, Riuko Ohashi, Koji Kitamura, Kotaro Saga, Yasuhide Yoshimura, et al. Local treatment of HVJ-E with T cell costimulatory molecule stimulation elicits systemic anti-tumor effects. Molecular therapy. Oncology. 2024. 32. 4. 200893-200893
Yuka Umeki, Noriaki Ogawa, Yuko Uegaki, Kotaro Saga, Yasufumi Kaneda, Keisuke Nimura. DNA barcoding and gene expression recording reveal the presence of cancer cells with unique properties during tumor progression. Cellular and molecular life sciences : CMLS. 2022. 80. 1. 17-17
Mari Wataya-Kaneda, Yoshiyuki Watanabe, Ayumi Nakamura, Kouji Yamamoto, Kiyoshi Okada, Shinichiro Maeda, Keisuke Nimura, Kotaro Saga, Ichiro Katayama. Pilot study for the treatment of cutaneous neurofibromas in neurofibromatosis type 1 patients using topical sirolimus gel. Journal of the American Academy of Dermatology. 2022. 88. 4. 877-880
Koji Kitamura, Keisuke Nimura, Rie Ito, Kotaro Saga, Hidenori Inohara, Yasufumi Kaneda. Author Correction: Evaluation of HPV16 E7 expression in head and neck carcinoma cell lines and clinical specimens (Scientific Reports, (2020), 10, 1, (22138), 10.1038/s41598-020-78345-8). Scientific Reports. 2021. 11. 1
Koji Kitamura, Keisuke Nimura, Rie Ito, Kotaro Saga, Hidenori Inohara, Yasufumi Kaneda. Evaluation of HPV16 E7 expression in head and neck carcinoma cell lines and clinical specimens. Scientific Reports. 2020. 10. 1

ｍore...

MISC (5)：

Norihiko Kawamura, Keisuke Nimura, Kotaro Saga, Yohei Okuda, Takuya Ito, Kentaro Takezawa, Koichi Tsutahara, Go Tanigawa, Tetsuya Takao, Yasufumi Kaneda, et al. Altered RNA splicing by SFX promotes malignancy in prostate cancer. INTERNATIONAL JOURNAL OF UROLOGY. 2018. 25. 186-186
Norihiko Kawamura, Keisuke Nimura, Kotaro Saga, Youhei Okuda, Takuya Ito, Kentaro Takezawa, Koichi Tsutahara, Go Tanigawa, Tetsuya Takao, Yasufumi Kaneda, et al. RNA splicing altered by SFX promotes malignancy in prostate cancer. INTERNATIONAL JOURNAL OF UROLOGY. 2018. 25. 349-349
川村憲彦, 佐賀公太郎, 河嶋厚成, 氏家剛, 永原啓, 藤田和利, 植村元秀, 野々村祝夫, 金田安史. 前立腺癌におけるAR-V7の発現制御機構. 日本癌学会総会記事. 2016. 75回. P-2241
Keisuke Nimura, Masamichi Yamamoto, Makiko Takeichi, Kotaro Saga, Katsuyoshi Takaoka, Norihiko Kawamura, Hirohisa Nitta, Hiromichi Nagano, Saki Ishino, Tatsuya Tanaka, et al. Abstract. eLife. 2016. 5
Masako Kawachi, Katsuto Tamai, Kotaro Saga, Takehiko Yamazaki, Hiroshi Fujita, Takashi Shimbo, Koji Nishifuji, Masayuki Amagai, Yasufumi Kaneda. A novel strategy for construction of tissue-targeting Sendai virus. JOURNAL OF GENE MEDICINE. 2008. 10. 4. 469-469

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page